We are live on
!
Find out more
BCM
Bronte Capital Management Portfolio holdings
AUM
$931M
1-Year Est. Return
47.97%
This Fund
S&P 500
This Quarter
Est. Return
+1.63%
1 Year Est. Return
+47.97%
3 Year Est. Return
+122.73%
5 Year Est. Return
+132.88%
10 Year Est. Return
–
AUM
$803M
AUM Growth
-$69.6M
(-8%)
Cap. Flow
-$20.9M
Cap. Flow
% of AUM
-2.6%
Top 10 Holdings %
Top 10 Hldgs %
79.73%
Holding
33
New
1
Increased
6
Reduced
13
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$7.05M |
| 2 |
HIBB
Hibbett, Inc. Common Stock
HIBB
|
+$4.45M |
| 3 |
Herbalife
HLF
|
+$2.96M |
| 4 |
Bath & Body Works
BBWI
|
+$2.72M |
| 5 |
Sotera Health
SHC
|
+$2.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$16.4M |
| 2 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$3.44M |
| 3 |
Albemarle
ALB
|
+$3.28M |
| 4 |
Newmont
NEM
|
+$3.14M |
| 5 |
Corteva
CTVA
|
+$2.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.09% |
| 2 | Communication Services | 18.52% |
| 3 | Healthcare | 13.51% |
| 4 | Consumer Staples | 12.7% |
| 5 | Materials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Riskified
RSKD
$829M
| $1.75M | 0.22% |
+443,480
| New | +$2.08M |
|
27
BioNTech
BNTX
$24.8B
| $937K | 0.12% |
6,948
| – | – |
|
|
DBTX
28
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $566K | 0.07% |
163,547
| – | – |
|
29
CALL
iShares Russell 2000 ETF
IWM
$77.1B
| – | – |
-94,100
| Closed | -$15.9M |
|
30
CALL
iShares Russell 2000 Growth ETF
IWO
$14.3B
| – | – |
-135,000
| Closed | -$27.9M |
|
|
31
Meta Platforms (Facebook)
META
$1.73T
| – | – |
-101,625
| Closed | -$16.4M |
|
|
32
Newmont
NEM
$131B
| – | – |
-52,574
| Closed | -$3.14M |
|
|
MACK
33
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| – | – |
-578,313
| Closed | -$3.44M |
|
Similar funds
AG
ACM
SAM
NS
PA
ACM
CICI
CAM
Bronte Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Bronte Capital Management held 33 positions worth $803M, down 8% from $873M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Bronte Capital Management's Q3 2022 filing shows 1 new, 6 increased, 13 reduced and 5 closed positions. Its largest new stake was Riskified: 443,480 shares worth $1.75M. The largest sale was Meta Platforms (Facebook), an estimated $16.4M.
By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 29% a quarter earlier, followed by Communication Services and Healthcare.
- Bronte Capital Management's largest Q3 2022 buy was Riskified: 443,480 shares worth $1.75M.
- Bronte Capital Management added most to Activision Blizzard in Q3 2022, an estimated $7.05M increase.
- Bronte Capital Management's biggest Q3 2022 reduction was Albemarle, cutting an estimated $3.28M.
- Bronte Capital Management fully exited Meta Platforms (Facebook) in Q3 2022, selling an estimated $16.4M.
- Bronte Capital Management's ten largest holdings make up 80% of its $803M portfolio in Q3 2022.
- Bronte Capital Management opened 1 new position and closed 5 in Q3 2022.
- Bronte Capital Management's portfolio value fell 8% quarter-over-quarter to $803M.
Based on Bronte Capital Management's 13F filing for Q3 2022, filed 3 Nov 2022.